Abbott Laboratories has seen significant activity in stock trading. Several investment and asset management firms have adjusted their holdings, with some reducing their stake and others acquiring more
shares. For instance,
Coppell Advisory Solutions LLC and
McAdam LLC have sold shares, weakening their stock positions, while entities like
Voleon Capital Management and
CTC Alternative Strategies Ltd. has invested significantly, showing increased confidence in Abbott Laboratories. Also, a note-worthy share purchase was carried out by
Focus Partners Wealth acquiring over 71,403 shares. This news is mirrored by activities of entities like
Woodline Partners LP and
Strs Ohio, among others, investing millions. A mixture of sales and purchases show a diverse
investment sentiment towards Abbott Laboratories in the market. There are warnings on upcoming
tariffs from Abbott Laboratory's CEO and questions raised regarding its
Q2 earnings and lower full-year guidance. However, analysts like Jim Cramer remain positive, citing potential
COVID-19-related concerns as driving factors.
Abbott Laboratories ABT News Analytics from Thu, 17 Apr 2025 07:00:00 GMT to Sat, 13 Sep 2025 19:54:03 GMT -
Rating 0
- Innovation 4
- Rumor 0
